Friedrich-Alexander-University Erlangen-Nürnberg

Jan 13, 2025 | translational-medicine.biomedcentral.com | RWTH Aachen |Uniklinik RWTH Aachen |Friedrich-Alexander-University Erlangen-Nürnberg

Correction Open access Published: 13 January 2025 Journal of Translational Medicine volume 23, Article number: 58 (2025) Cite this article The Original Article was published on 12 December 2023 Journal of Translational Medicine volume 21, Article number: 908 (2023)Following publication of the original article [1], we have been notified that Author contributions’ declaration was published incorrectly.

Jul 22, 2024 | academic.oup.com | Friedrich-Alexander-University Erlangen-Nürnberg |Universitätsklinikum Erlangen |Deutsches Zentrum Immuntherapie |Friedrich-Alexander Universität Erlangen-Nürnberg

Hypothesizing that early treatment yields improved prognosis, we aimed to investigate how the timing of immunosuppressive treatment relates to interstitial lung disease (ILD) development and the course of pulmonary function in systemic sclerosis (SSc).

Jun 27, 2024 | academic.oup.com | Friedrich-Alexander-University Erlangen-Nürnberg |Universitätsklinikum Erlangen

We thank Prof. Boyd and colleagues for their interesting comments highlighting the growing importance of internal bone mineral density (BMD) calibration techniques for use in opportunistic screening. We agree that the phantomless BMD calibration method developed at the University of Calgary1 is easier to use than other methods because it does not require an external reference data set.

Apr 30, 2024 | karger.com | Friedrich-Alexander-University Erlangen-Nürnberg

Keywords: Internet intervention, Transdiagnostic prevention, Subthreshold disorders, Subclinical anxiety, Subclinical depression Subclinical anxiety and depressive symptoms that do not meet full diagnostic criteria are highly prevalent [1, 2] and increase the risk of developing full-syndrome disorders [3]. Similar to full-syndrome disorders, subclinical anxiety and depression symptoms often co-occur.

Jan 1, 2024 | actaneurocomms.biomedcentral.com | Friedrich-Alexander-University Erlangen-Nürnberg |Friedrich-Alexander-Universität Erlangen-Nürnberg

Post mortem cortex, putamen and substantia nigra of MSA-P patients and age- and sex-matched controls (each n = 4, Table 1) were obtained from the Netherlands Brain Bank (NBB), Netherlands Institute for Neuroscience, Amsterdam (open access: http://www.brainbank.nl). MSA cases were clinically diagnosed and neuropathologically confirmed as MSA-P according to the second consensus criteria (Table 1; [36]).